← All organizations

A*Star

Government

Also known as: A*Star | A*STAR Infectious Diseases Labs | D3 (Drug Discovery and Development), Biomedical Sciences Institute | D3, Senior Medical Director | EDDC (Experimental Drug Development Centre), A*STAR Research Entities | E-Star BioTech, LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 30, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (16 distinct, 10 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (7 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

inactivated covid-19 vaccine

Indications

Studied for

Recent trials (13)

NCT06513624CollaboratorPhase 1Nov 30, 2024
NCT06343298OfficialPhase 2Sep 25, 2024
NCT06343298Lead sponsorPhase 2Sep 25, 2024
NCT06654973CollaboratorN/AAug 27, 2024
NCT05701527Lead sponsorPhase 1Apr 28, 2023
NCT05701527Study directorPhase 1Apr 28, 2023
NCT05479370CollaboratorPhase 3Sep 29, 2022
NCT05247528Lead sponsorPhase 1Dec 20, 2021
NCT05142319CollaboratorPhase 3Oct 12, 2021
NCT04930744CollaboratorPhase 2Aug 3, 2021
NCT02521844Lead sponsorPhase 1Oct 1, 2015
NCT02521844Study directorPhase 1Oct 1, 2015
NCT02774993CollaboratorPhase 2Sep 1, 2015

Details

Last known activity: Nov 30, 2024